256 related articles for article (PubMed ID: 16738197)
41. [Comments of the DGP on the press release dated 21.10. 2011 of the National Heart, Lung and Blood Institute about the PANTHER Study on IPF patients].
Behr J; Costabel U; Worth H
Pneumologie; 2011 Dec; 65(12):724-5. PubMed ID: 22144038
[No Abstract] [Full Text] [Related]
42. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
[No Abstract] [Full Text] [Related]
43. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Izumi S; Iikura M; Hirano S
N Engl J Med; 2012 Aug; 367(9):870; author reply 870-1. PubMed ID: 22931326
[No Abstract] [Full Text] [Related]
44. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Uruga H; Hanada S; Kishi K
N Engl J Med; 2012 Aug; 367(9):870; author reply 870-1. PubMed ID: 22931325
[No Abstract] [Full Text] [Related]
45. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Behr J
N Engl J Med; 2012 Aug; 367(9):869; author reply 870-1. PubMed ID: 22931324
[No Abstract] [Full Text] [Related]
46. [Long term development of idiopathic pulmonary fibrosis. Combined therapy with immunodepressors, D-penicillamine and corticosteroids].
Meier-Sydow J; Connette B; Hübel E; Kroidl RF; Kronenberger H; Müller U; Rust M; Thiel C
Bronchopneumologie; 1979; 29(3):249-54. PubMed ID: 509328
[No Abstract] [Full Text] [Related]
47. [Idiopathic pulmonary fibrosis -- progress in sight].
Kaarteenaho R; Hodgson U; Myllärniemi M
Duodecim; 2011; 127(24):2639-45. PubMed ID: 22320106
[TBL] [Abstract][Full Text] [Related]
48. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
; Raghu G; Anstrom KJ; King TE; Lasky JA; Martinez FJ
N Engl J Med; 2012 May; 366(21):1968-77. PubMed ID: 22607134
[TBL] [Abstract][Full Text] [Related]
49. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
Bonella F; Wessendorf TE; Costabel U
Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
[TBL] [Abstract][Full Text] [Related]
50. Pirfenidone treatment of idiopathic pulmonary fibrosis.
Azuma A
Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
[TBL] [Abstract][Full Text] [Related]
51. Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial.
Selman M; Carrillo G; Salas J; Padilla RP; Pérez-Chavira R; Sansores R; Chapela R
Chest; 1998 Aug; 114(2):507-12. PubMed ID: 9726738
[TBL] [Abstract][Full Text] [Related]
52. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
Azuma A
Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
[TBL] [Abstract][Full Text] [Related]
53. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
54. [Comparative study between oral azathioprine and intravenous cyclophosphamide pulses in the treatment of idiopathic pulmonary fibrosis].
Roig V; Herrero A; Arroyo-Cózar M; Vielba D; Juarros S; Macías E
Arch Bronconeumol; 2010 Jan; 46(1):15-9. PubMed ID: 19879035
[TBL] [Abstract][Full Text] [Related]
55. [Therapy of diffuse pulmonary fibrosis (including prevention of development and progression)].
Dierkesmann R; Cegla UH; Meier-Sydow J; Kroidl R
Internist (Berl); 1974 Jul; 15(7):386-90. PubMed ID: 4608973
[No Abstract] [Full Text] [Related]
56. [A case of idiopathic pulmonary fibrosis with histology of usual interstitial pneumonia that responded to pulse therapy followed by combined immunosuppression with prednisolone and azathioprine].
Shishido M; Ichiki H; Yano M; Toda K; Ohtsuki Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2139-45. PubMed ID: 1289636
[TBL] [Abstract][Full Text] [Related]
57. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.
Raghu G; Johnson WC; Lockhart D; Mageto Y
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1061-9. PubMed ID: 10194146
[TBL] [Abstract][Full Text] [Related]
58. [Expectation of new treatments for idiopathic interstitial pneumonias].
Azuma A
Nihon Ronen Igakkai Zasshi; 2005 Jan; 42(1):27-30. PubMed ID: 15732351
[TBL] [Abstract][Full Text] [Related]
59. Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.
Wells AU
Eur Respir J; 2006 Apr; 27(4):664-6. PubMed ID: 16585071
[No Abstract] [Full Text] [Related]
60. Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation.
Wahidi MM; Ravenel J; Palmer SM; McAdams HP
Chest; 2002 Jun; 121(6):2072-6. PubMed ID: 12065382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
